Lynn Baranowski

CEO

Equibles does not estimate personal net worth.

About Lynn Baranowski

Lynn Baranowski is recorded as CEO at Avalyn Pharma Inc. (AVLN). Lynn Baranowski has spoken on 1 investor event across 1 company, most recently for Avalyn Pharma Inc. on September 14, 2026. Avalyn Pharma Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Avalyn Pharma Inc. includes Robert Meyer, M.D. (Board Member).

Lynn Baranowski on recent calls

“I'm looking forward to getting to know those of you that I don't. I'm the CEO. The company was founded in 2017 with a Series A. I joined in 2022 as the CEO. We're focused entirely in pulmonary fibrosis.”

CEO, Morgan Stanley 24th Annual Global Healthcare Conference · September 14, 2026